These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22152183)

  • 41. Effectiveness of superficial venous surgery in terms of quality-adjusted life years and costs.
    Eskelinen E; Räsänen P; Albäck A; Lepäntalo M; Eskelinen A; Peltonen M; Roine RP
    Scand J Surg; 2009; 98(4):229-33. PubMed ID: 20218420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure.
    Linko R; Suojaranta-Ylinen R; Karlsson S; Ruokonen E; Varpula T; Pettilä V;
    Crit Care; 2010; 14(2):R60. PubMed ID: 20384998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Costs and Cost-Utility of Critical Care and Subsequent Health Care: A Multicenter Prospective Study.
    Jukarainen S; Mildh H; Pettilä V; Häkkinen U; Peltola M; Ala-Kokko T; Reinikainen M; Vaara ST
    Crit Care Med; 2020 May; 48(5):e345-e355. PubMed ID: 31929342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using QALYs in telehealth evaluations: a systematic review of methodology and transparency.
    Bergmo TS
    BMC Health Serv Res; 2014 Aug; 14():332. PubMed ID: 25086443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010.
    Wisløff T; Hagen G; Hamidi V; Movik E; Klemp M; Olsen JA
    Pharmacoeconomics; 2014 Apr; 32(4):367-75. PubMed ID: 24477679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of "quality-adjusted life years" (QALYs) to evaluate treatment in intensive care.
    Kerridge RK; Glasziou PP; Hillman KM
    Anaesth Intensive Care; 1995 Jun; 23(3):322-31. PubMed ID: 7573919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economic evaluation of MARS--preliminary results on survival and quality of life.
    Hessel FP; Mitzner SR; Rief J; Gress S; Guellstorff B; Wasem J
    Liver; 2002; 22 Suppl 2():26-9. PubMed ID: 12220299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Approach to economic analysis in critical care.
    Kyeremanteng K; Wan C; D'Egidio G; Neilipovitz D
    J Crit Care; 2016 Dec; 36():92-96. PubMed ID: 27546754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Palliative ICU beds for potential organ donors: an effective use of resources based on quality-adjusted life-years gained.
    Nunnink L; Cook DA
    Crit Care Resusc; 2016 Mar; 18(1):37-42. PubMed ID: 26947414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality-adjusted life-years for the estimation of effectiveness of screening programs: a systematic literature review.
    Mäklin S; Räsänen P; Laitinen R; Kovanen N; Autti-Rämö I; Sintonen H; Roine RP
    Int J Technol Assess Health Care; 2012 Apr; 28(2):145-51. PubMed ID: 22559756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Common effect measures in medical and health economics studies? Results of an exploratory survey of physicians].
    König HH; Hoffmann C; Graf von der Schulenburg JM; Leidl R
    Med Klin (Munich); 1999 Dec; 94(12):665-72. PubMed ID: 10641508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Survey of analytical works for drugs at emergency and critical care centers with high-performance instruments provided by the Ministry of Health and Welfare (at present: Ministry of Health, Labour, and Welfare) in fiscal 1998--continuation of survey with 2008 survey results as point of reference].
    Saito T; Tominaga A; Nozawa M; Unei H; Hatano Y; Fujita Y; Iseki K; Hori Y; ;
    Chudoku Kenkyu; 2013 Sep; 26(3):226-33. PubMed ID: 24224387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health-related quality-of-life and health-utility reporting in critical care.
    Lau VI; Johnson JA; Bagshaw SM; Rewa OG; Basmaji J; Lewis KA; Wilcox ME; Barrett K; Lamontagne F; Lauzier F; Ferguson ND; Oczkowski SJW; Fiest KM; Niven DJ; Stelfox HT; Alhazzani W; Herridge M; Fowler R; Cook DJ; Rochwerg B; Xie F
    World J Crit Care Med; 2022 Jul; 11(4):236-245. PubMed ID: 36051941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calculating QALYs, comparing QALY and DALY calculations.
    Sassi F
    Health Policy Plan; 2006 Sep; 21(5):402-8. PubMed ID: 16877455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One-Year Quality of Life Post-Pneumonia Diagnosis in Japanese Adults.
    Glick HA; Miyazaki T; Hirano K; Gonzalez E; Jodar L; Gessner BD; Isturiz RE; Arguedas A; Kohno S; Suaya JA
    Clin Infect Dis; 2021 Jul; 73(2):283-290. PubMed ID: 32447366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of the EQ-5D Instrument and Value Scale in Comparing Health States of Patients in Four Health Care Programs among Health Care Providers.
    Rupel VP; Ogorevc M
    Value Health Reg Issues; 2014 Sep; 4():95-99. PubMed ID: 29702814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dimensions Used in Instruments for QALY Calculation: A Systematic Review.
    Touré M; Kouakou CRC; Poder TG
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33919471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of life and time to death: have the health gains of preventive interventions been underestimated?
    Gheorghe M; Brouwer WB; van Baal PH
    Med Decis Making; 2015 Apr; 35(3):316-27. PubMed ID: 25341681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A note on QALYs, time tradeoff, and discounting.
    Johannesson M; Pliskin JS; Weinstein MC
    Med Decis Making; 1994; 14(2):188-93. PubMed ID: 8028472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantifying life: Understanding the history of Quality-Adjusted Life-Years (QALYs).
    MacKillop E; Sheard S
    Soc Sci Med; 2018 Aug; 211():359-366. PubMed ID: 30015244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.